Figure 2.

Transitional serum biomarkers for liver cancer and osteosarcoma. Combined therapy with surgical resection after chemotherapy resulted in a significant decrease in serum tumor markers for liver cancer and osteosarcoma. AFP and L-3 are serum markers for the hepatic tumor, whereas LDH and ALP are serum markers for the osteosarcoma

Yoshida et al. BMC Cancer 2012 12:444   doi:10.1186/1471-2407-12-444
Download authors' original image